Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02601326
Other study ID # Mansourau24
Secondary ID
Status Completed
Phase N/A
First received October 28, 2015
Last updated March 14, 2016
Start date January 2012
Est. completion date December 2015

Study information

Verified date November 2015
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority Egypt: Institutional Review Board
Study type Interventional

Clinical Trial Summary

A comparative randomized study between laparoscopic ventral mesh Rectopexy and Delorme's procedure in treatment of complete rectal prolapse to ass both efficacy and complications


Description:

A comparative randomized study between laparoscopic ventral mesh Rectopexy and Delorme's procedure in treatment of complete rectal prolapse to ass both efficacy and complications.

Follow up is scheduled for 18 months to evaluate recurrence, continence state and complications


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 2015
Est. primary completion date January 2014
Accepts healthy volunteers No
Gender Both
Age group 16 Years to 70 Years
Eligibility Inclusion Criteria:

- patients with complete rectal prolapse

Exclusion Criteria:

- patients who underwent previous surgery for complete rectal prolapse

- patients unfit for surgery

- patients with associated colorectal diseases or pathology

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Laparoscopic ventral mesh Rectopexy
Laparoscopic fixation of rectum to sacral promontory using mesh
Delorme's procedure
Transanal excision of rectal mucosa and plication of muscle layer

Locations

Country Name City State
Egypt Mansoura university hospital Mansoura Dakahlia

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recurrence of the condition Measured by counting the number of patients with recurrence of rectal prolapse 18 month No